CMF
BSX icon

Counterpoint Mutual Funds’s Boston Scientific BSX Stock Holding History

Counterpoint Mutual Funds’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,016
Closed -$252K – 312
2026
Q1 		$252K Sell
4,016
-1,264
-24% -$101K 0.04% 280
2025
Q4 		$503K Buy
5,280
+2,176
+70% +$213K 0.04% 136
2025
Q3 		$303K Buy
+3,104
New +$321K 0.02% 308
2023
Q2 		– Sell
-1,804
Closed -$90.3K – 317
2023
Q1 		$90.3K Buy
+1,804
New +$85K 0.08% 302

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Counterpoint Mutual Funds's BSX Position: Q2 2026 in Review

Counterpoint Mutual Funds sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,016 shares — an estimated $252K sold.

Counterpoint Mutual Funds first reported a position in BSX in Q1 2023 and held it in 4 quarters. The position peaked at $503K in Q4 2025. 343 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Counterpoint Mutual Funds reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 4,016 Boston Scientific shares in Q2 2026, an estimated $252K.
  • Counterpoint Mutual Funds first reported a position in Boston Scientific in Q1 2023 and held it in 4 quarters.
  • Counterpoint Mutual Funds's Boston Scientific position peaked at $503K in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.